Literature DB >> 15290860

Aerosol dispersion of respirable particles in narrow size distributions produced by jet-milling and spray-drying techniques.

Margaret D Louey1, Michiel Van Oort, Anthony J Hickey.   

Abstract

PURPOSE: To examine the effect of particle size and morphology on aerosol dispersion using jet-milled and spray-dried mannitol particles in narrow size distributions within the respirable range.
METHODS: Particle size and morphology were examined by laser diffraction and scanning electron microscopy, respectively. Aerosol dispersion was examined using a cascade impactor with a preseparator operating at a flow rate of 60 L/min, using two inhaler devices: Rotahaler (low-resistance device) and Inhalator (high-resistance device). Powder flow was examined using static and dynamic methods (Carr's compressibility index and vibrating spatula, respectively).
RESULTS: Narrow size distributions of jet-milled and spray-dried particles were produced (d50% = 1.4 to 10.3 microm, GSD = 1.8 to 2.1, and d50% = 1.6 to 7.5 microm; GSD = 1.5 to 1.9, respectively). All particles were highly crystalline. Differences in particle shape were observed between jet-milled and spray-dried particles. Higher fine particle fraction (FPF) and relative fine particle fraction (FPFrel) (greater aerosol dispersion) and lower geometric standard deviation (GSD) (less variation) were obtained using particles with d50% between 2 and 5 microm. Higher mass median aerodynamic diameter were obtained with larger d50%. Spray-dried particles produced greater aerosol dispersion compared with jet-milled particles. Greater aerosol dispersion was obtained using the Inhalator than the Rotahaler.
CONCLUSIONS: Small changes in the particle size within the 1-10-microm range produced a major impact in the aerosol dispersion of jet-milled and spray-dried particles. Even in these narrow size ranges, aggregation plays an important role in aerosol dispersion.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15290860     DOI: 10.1023/b:pham.0000033007.27278.60

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  5 in total

1.  Influence of particle size, air flow, and inhaler device on the dispersion of mannitol powders as aerosols.

Authors:  N Y Chew; H K Chan
Journal:  Pharm Res       Date:  1999-07       Impact factor: 4.200

2.  The relationship between powder inhaler resistance and peak inspiratory conditions in healthy volunteers--implications for in vitro testing.

Authors:  A R Clark; A M Hollingworth
Journal:  J Aerosol Med       Date:  1993

3.  Prediction of drug residence times in regions of the human respiratory tract following aerosol inhalation.

Authors:  P R Byron
Journal:  J Pharm Sci       Date:  1986-05       Impact factor: 3.534

4.  Effect of particle size, air flow and inhaler device on the aerosolisation of disodium cromoglycate powders.

Authors:  N Y Chew; D F Bagster; H K Chan
Journal:  Int J Pharm       Date:  2000-09-25       Impact factor: 5.875

5.  Colorimetric Assay of Alditols in Complex Biological Samples.

Authors: 
Journal:  J Agric Food Chem       Date:  1998-01-19       Impact factor: 5.279

  5 in total
  8 in total

1.  Aerosol dispersion of respirable particles in narrow size distributions using drug-alone and lactose-blend formulations.

Authors:  Margaret D Louey; Michiel Van Oort; Anthony J Hickey
Journal:  Pharm Res       Date:  2004-07       Impact factor: 4.200

2.  Effects of device and formulation on in vitro performance of dry powder inhalers.

Authors:  Wallace P Adams; Sau L Lee; Robert Plourde; Robert A Lionberger; Craig M Bertha; William H Doub; Jean-Marc Bovet; Anthony J Hickey
Journal:  AAPS J       Date:  2012-04-05       Impact factor: 4.009

3.  Effect of particle shape on dry particle inhalation: study of flowability, aerosolization, and deposition properties.

Authors:  Meer Saiful Hassan; Raymond Wai Man Lau
Journal:  AAPS PharmSciTech       Date:  2009-10-29       Impact factor: 3.246

4.  Simultaneous Particle Size Reduction and Homogeneous Mixing to Produce Combinational Powder Formulations for Inhalation by the Single-Step Co-Jet Milling.

Authors:  Junhong Ling; Sharad Mangal; Heejun Park; Shaoning Wang; Alex Cavallaro; Qi Tony Zhou
Journal:  J Pharm Sci       Date:  2019-05-18       Impact factor: 3.534

5.  Phase I, single-dose, dose-escalating study of inhaled dry powder capreomycin: a new approach to therapy of drug-resistant tuberculosis.

Authors:  Ashwin S Dharmadhikari; Mohan Kabadi; Bob Gerety; Anthony J Hickey; P Bernard Fourie; Edward Nardell
Journal:  Antimicrob Agents Chemother       Date:  2013-03-25       Impact factor: 5.191

6.  Investigation into alternative sugars as potential carriers for dry powder formulation of budesonide.

Authors:  Mohammed-Nurul Momin; Atoosa Hedayati; Ali Nokhodchi
Journal:  Bioimpacts       Date:  2011-08-05

7.  Preparation and in vivo evaluation of a dry powder for inhalation of capreomycin.

Authors:  Jennifer Fiegel; Lucila Garcia-Contreras; Matthew Thomas; Jarod VerBerkmoes; Katharina Elbert; Anthony Hickey; David Edwards
Journal:  Pharm Res       Date:  2007-07-27       Impact factor: 4.200

8.  Evidence for the existence of powder sub-populations in micronized materials: aerodynamic size-fractions of aerosolized powders possess distinct physicochemical properties.

Authors:  Sara Jaffari; Ben Forbes; Elizabeth Collins; Jiyi Khoo; Gary P Martin; Darragh Murnane
Journal:  Pharm Res       Date:  2014-12       Impact factor: 4.200

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.